INTRODUCTION:

The global healthcare landscape is significantly challenged by autoimmune diseases, a predicament further complicated by the diverse healthcare system in India. Diabetes Mellitus, a prominent autoimmune condition, exacerbates the strain on healthcare infrastructure and imposes a significant socioeconomic burden¹. The rising prevalence of autoimmune diseases, especially Diabetes Mellitus, is attributed to a complex interplay of changing lifestyles, dietary habits, genetic factors, and environmental influences². This intricate interplay has led to an increase in prevalence, necessitating a comprehensive approach from healthcare authorities and researchers to effectively manage the burden of these diseases³.

The impact of this upward trend extends beyond individual health, intertwining with the very fabric of India's public health resources⁴. Understanding the depth of this issue is crucial for developing nuanced strategies to alleviate the burden of autoimmune diseases within the country. Amidst this complexity, exploring India's traditional medicinal practices offers a promising avenue. Deeply rooted in cultural heritage, these practices hold potential for treating autoimmune disorders, particularly Diabetes Mellitus. Investigating the integration of traditional medicinal plant-based approaches into modern healthcare can provide valuable insights and innovative disease management strategies⁵.

Diabetes Mellitus:

Diabetes mellitus (DM), often described as "starvation in the midst of plenty," is a multifaceted challenge characterized by impaired cellular glucose transfer. In Type 2 Diabetes Mellitus (T2DM), a dynamic interplay of hyperglycemia, insulin resistance, and insufficient insulin production by pancreatic islet cells perpetuates chronic high blood sugar levels⁶. Contrary to the traditional perception of T2DM as an older adult's disease, its prevalence has expanded to younger demographics⁷. This metabolic disorder affects 200 million people globally, with 41 million cases in India, driven by relative or absolute insulin deficiency and cellular resistance to insulin⁸.

The epidemiological landscape predicts a rise in DM prevalence from 2.8% in 2000 to 5.4% by 2025. Current treatments, including insulin and oral hypoglycemic agents, are economically challenging, especially in developing countries⁹. In this context, natural remedies based on plant-derived formulations are gaining popularity¹⁰. Traditional home-grown medications, integral to DM management, are valued for their low adverse reaction rates and cost-effectiveness¹¹. With over a thousand plant genera identified, these natural hypoglycemic agents play a crucial role¹². The biochemical mechanisms of these plant products, rich in phenolic mixtures, flavonoids, and terpenoids, offer a gradual reduction in blood sugar levels¹³. As scientific research recognizes the antidiabetic efficacy of various natural medicines, the scope of DM management is expanding to include pharmacologically tested, home-grown remedies¹⁴.

Figoure.01:-Graphical Abstract

Diabetes Mellitus: Unraveling Complexity across Organs:

Diabetes mellitus unfolds as a complex, multi-systemic malady, intricately weaving its repercussions across various bodily organs¹⁵. Renowned for its well-documented consequences such as diabetic retinopathy and nephropathy, which propel individuals toward advanced renal diseases, nerve ailments, and macroangiopathy paving the way for cardiovascular complications and non-traumatic limb amputations¹⁶. Yet, amidst this intricate medical narrative, the lung stands as an intriguingly understudied terrain in the realm of diabetic damage. The term "diabetic pneumopathy" fails to find its place in the recognized lexicon of medical literature, casting a veil of mystery over the potential intricacies of pulmonary involvement in diabetes¹⁷. As the narrative of diabetes unfolds its impact on diverse physiological systems, the enigma surrounding the lung's role as a potential target organ beckons further exploration, inviting the medical community to delve into the nuanced complexities of this lesser-explored dimension of diabetic pathophysiology¹⁸.

Figure 02: Impact of diabetes on several organ systems

The Significance of Traditional Medicinal Plant-Based Management:

In the healthcare sector, traditional medicinal plant-based management stands out, especially for autoimmune diseases like Diabetes Mellitus in India¹⁹. These ancient practices, deeply rooted in indigenous knowledge, offer unique therapeutic options and holistic perspectives for disease management. With bioactive compounds derived from plants, these methods present alternative or complementary therapies, providing a natural and well-tolerated option to conventional pharmaceutical treatments.

Benefits and Sustainability:

Traditional medicinal plants counteract the limitations and side effects associated with standard pharmaceuticals. These natural remedies not only expand the treatment options but also align with sustainability principles²⁰. Locally sourced, they support biodiversity conservation and enhance the livelihoods of indigenous communities involved in their cultivation and harvesting²¹.

Comprehensive Evaluation:

This review explores the complex landscape of autoimmune diseases, focusing on the challenge posed by Diabetes Mellitus in India²². It examines the prevalence, determinants, and socio-cultural influences of these conditions, highlighting the crucial role traditional medicinal plants play in their management²³. The goal is to bridge the gap between conventional medical practices and the rich indigenous knowledge of India's traditional medicinal systems²⁴. By integrating recent research, clinical studies, and historical perspectives, this review offers a comprehensive understanding of how traditional medicinal plants can be central to managing autoimmune diseases in India²⁵.

Epidemiological Insights:

Understanding the epidemiology of autoimmune diseases, particularly Diabetes Mellitus, requires analyzing their prevalence, incidence, and trends. This analysis provides critical insights for developing effective healthcare management strategies²⁶.

Detailed exploration of specific plants traditionally used in managing Diabetes Mellitus:

In various cultures, including India, traditional medicinal plants have historically played a significant role in the management of autoimmune diseases like Diabetes Mellitus (DM)²⁷. These plants provide a substantial supply of bioactive compounds that have the potential to regulate immune responses, lessen inflammation, and aid in the management of autoimmune conditions-related symptoms²⁸.

Table 1:Diabetes Mellitus is managed with herbal plants

SN	Plant name (botanical)	Family	Part	Chemical constituents /Mode of action/Uses	References
1	Momordica charantia	Cucurbitaceae	whole plant	Amidst the arcane tapestry of Indian healing, The enigmatic bitter melon, unveils its anti-diabetic. A revealing a difficult yet harmonious of metabolic equilibrium.	29
2	Emblica officinalis	Euphorbiaceae	Fruit, Leave	Bursting with vitamin C and polyphenols, it orchestrates a symphony of benefits—enhancing pancreatic function, regulating blood sugar, and diminishing oxidative stress.	30
3	Trigonella foenum-graecum	Euphorpiaceae		fiber and saponins, notably trigonelline, they conduct a symphony of glycemic mastery, enhancing insulin sensitivity, orchestrating a measured slowdown in carbohydrate absorption, and choreographing superior glycemic control.	31
4	Cinnamomum verum	Lauraceae	Bark	cinnamaldehyde and polyphenols, it orchestrates an antidiabetic symphony, enhancing insulin sensitivity, gracefully lowering fasting blood sugar levels, and possibly diminishing cardiovascular risks	32
5	Gymnema Sylvestre	Apocynaceae		Gurmar, the sugar destroyer, gymnemic acids, it dances in the realm of antidiabetic prowess, potentially curbing sugar absorption, enhancing insulin production, and tempering sugar cravings.	33
6	Abroma augusta	Sterculiaceae	Root	abromine, abromasterol, quercetin, and kaempferol, it orchestrates a symphony of insulin enhancement, glucose uptake, and β-cell fortification, promising support for diabetes management in Ayurveda.	34
7	Acacia arabica	Fabeceae	Bark	Anti-diabetic prowess ,flavonoids - quercetin, kaempferol, tannins, and glycosides, it orchestrates a symphony of insulin sensitivity, enzyme inhibition, and blood sugar control, heralding a promising frontier in herbal diabetic management.	35
8	Acalypha wilkesiana	Euphorpiaceae	Leaves	Adorned in flavonoids and phenolic mystique, it choreographs insulin sensitivity, battles oxidative realms, and dances with α-glucosidase inhibition. A herald in traditional realms beckoning diabetes management's evolution.	36
9	Acorus calamus	Acoraceae	Leaves/bark	β-asarone and α-asarone. Unveiling whispers of anti-diabetic potential, it orchestrates insulin sensitivity, sugar symphonies, and pancreatic support. A prospect in diabetes, a herbal sonnet awaiting resonance.	37
10	Aegle marmelos	Rutaceae	Leaves/bark/root	rutin, quercetin, and marmelosin. A ballet of flavonoids and alkaloids orchestrates anti-diabetic prowess, choreographing insulin dance and glucose harmony. A herbal sonnet beckoning trials, promising diabetes serenity.	38
11	Afzeliaafricana	Fabaceae	Stem bark	flavonoids, saponins, and alkaloids. In the diabetic realm, its potential, though shadowed, hints at insulin sensitivity and blood sugar ballet	39
12	Alhagi camelorum	Fabaceae	Aerial part	alkaloids, flavonoids, and saponins. In diabetes's cryptic dance, it tentatively unveils potential in insulin sensitivity enhancement and glucose orchestration. A trailblazer, yet cloaked; demanding the spotlight of rigorous scrutiny.	40
13	Allium sattivum	Alliaceae	Bulb	allicin, alliin, and diallyl trisulfide, whispers secrets of anti-diabetic prowess. Its intricate dance, enhancing insulin sensitivity and quelling resistance, unfurls a saga of blood sugar modulation.	41
14	Aloe barbadensis miller	Xanthorrhocaceae	Leaves	polysaccharides, glycoproteins, and anthraquinones, tantalizes with potential anti-diabetic prowess.	42
15	Alpinia officinarum	Zingiberaceae	Rhizomes	Guarded by essential oils—cineole, terpinene, and an alchemy of flavonoids. A diabetes waltz, its potential teased in preliminary studies, whispers of insulin's embrace.	43
16	Amaranthus spinosus, Amaranthus viridis	Amaranthaceae	Leaves	flavonoids, phenolics, and saponins. anti-diabetic prowess echo through studies, teasing with antioxidant grace, potentially choreographing glucose ballet	44
17	Annona squamosa	Annonaceae	Fruits	acetogenins, squamocin, and flavonoids. Whispers of anti-diabetic prowess dance through its bioactive compounds, orchestrating an antioxidant symphony, potentially harmonizing blood sugar and insulin.	45
18	Anogeissus acuminate	Combretaceae	Whole plant	ellagic acid, flavonoids, and tannins. While research on its anti-diabetic properties is limited, preliminary studies suggest potential in managing diabetes.	46
19	Areca catechu	Arecaceae	Seed	arecoline and flavonoids, whispering in the realm of diabetes management.	47
20	Artemisia dracunculus (L.)	Asteraceae	Aerial part	polyphenols and essential oils, unfolds a perplexing narrative. Recognized for anti-diabetic potential	48
21	Artemisia pallens	Asteaceae	Leaves and Flower	coumarins, sesquiterpenes, and flavonoids. Though diabetes intrigue surrounds it, research limitations perplex.	49
22	Aspidosperma macrocarpon	Apocynaceae	Steam/Bark Root wood	indole mysteries—macrocarpamine, macrocarpaline—it dances in anti-diabetic scrutiny. Hints at insulin symphonies, glucose riddles spark,	50
23	Atractylodesmacrocephala	Asteraceae	Whole plant	atractylenolides, oils, polysaccharides, it dances in anti-diabetic scrutiny. Hints at insulin symphonies, glucose mysteries spark, beckoning rigorous trials for efficacy, safety unveilings.	51
24	Azadirachta indica	Meliaceae	Leaves, flower and seed	nimbin whispers, nimbidin echoes, and flavonoid dances. In diabetic realms, its cryptic compounds choreograph a symphony—stimulating insulin, curtailing glucose, beckoning clinical scrutiny for efficacy, safety revelations.	52
25	Belamcanda chinensis	Irdaceae	Leaves	isoflavones, kaempferol, and quercetin. In diabetes realms, a subtle unfolds—antioxidant whispers, insulin sensitivity whispers—promising tales of sugar control.	53
26	Benincasa hispida	Cucurbitaceae	Fruit	Adorned with flavonoids and terpenoids. In the diabetes symphony, it teases modulation, insulin whispers, and antioxidant hums—a cultural elixir promising metabolic harmony.	54
27	Berberis vulgaris	Berberidaceae	Leaves	alkaloids—berberine, berbamine, oxyacanthine—a potion for diabetes intrigue.	55
28	Beta vulgaris	Amaranthaceae	Root	betalains, betacyanins, and nitrate elixirs. Amidst whispers of vascular magic, Beetroot hints at anti-diabetic prowess—betalains pirouette, orchestrating glucose alchemy and insulin sensitivity ballet.	56
30	Aspidosperma macrocarpon	Apocynaceae	bark	indole enigmas—macrocarpamine, macrocarpaline—it dances in anti-diabetic scrutiny. Hints at insulin symphonies	57
31	Syzygium aromaticum	Myrtaceae	Flowering buds	Eugenol, a prime player, orchestrates hypoglycemic ballet. Clove extracts wield glucose-suppressing wizardry, offering therapeutic promise in diabetes management, substantiated by diverse scientific endeavors.	58
32	Swertia chirata	Gentianaceae	Whole plant	mangiferin and swertiamarin. These elements intricately orchestrate glucose control, presenting Swertia chirata as a captivating contender in diabetes care.	59
33	Rumex maritimus	naphthalenes	leaves	anthraquinones, naphthalenes, flavonoids, stilbenoids, and triterpenes, presents a paradox—potent anti-diabetic potential and root extracts unveiling an unexpected role in battling diarrhea.	60

Unraveling the Diabetes Tapestry in India:

The enigmatic surge of immune disorders, especially Diabetes Mellitus (DM), paints a complex canvas in India^133,134. Extensive studies reveal a stark escalation in DM prevalence, both Type 1 and Type 2⁶¹. Type 1 DM, an autoimmune onslaught on pancreatic cells, surges among the young, attributing the rise to genetic predisposition, environment, and shifting lifestyles. Simultaneously, Type 2 DM, entwined with sedentary habits and poor diet, skyrockets due to urbanization and hereditary factors⁶². The burden of DM weaves into economic intricacies, fueled by inadequate awareness, limited healthcare access, and escalating treatment costs⁶³.

Figure:03 List of plants to regulate diabetes

DISCUSSION:

The landscape of autoimmune diseases, encompassing Diabetes Mellitus (DM), in India unfolds as a perplexing tapestry of health challenges. With over 5% of the global population affected, the burden is magnified by the intricate interplay of shifting lifestyles, genetic predispositions, and environmental impacts⁶³. DM, metaphorically termed "starvation in the midst of plenty," accentuates the complexity with cellular glucose transfer impediments. Type 2 DM, once perceived as an affliction of the elderly, now surges in the younger demographic, contributing to the global prevalence of 200 million affected individuals, with 41 million in India alone⁶⁴.

Traditional medicinal plants, deeply rooted in India's botanical diversity, offer a perplexing yet promising avenue for managing immune disorders, particularly DM. The review navigates this intricate labyrinth, spotlighting anti-diabetic plants in a burst of information that blends conventional and commercial perspectives. Ayurvedic formulations, Chinese traditional remedies, and Unani practices contribute to the narrative rich in hypoglycemic properties of these botanical treasures⁶⁵.

Diabetes is a problem with how carbohydrates, fats, and proteins are digested that is brought on by a lack of insulin production or by its inhibitory effect. It is a significant source of severe financial loss and can impede national growth⁶⁶.Common remedies were used before there were pharmaceuticals from pharmaceutical companies, and they are still in use today⁶⁷. Many plants have potent anti-diabetic effects. Patients with insulin-dependent and non-insulin-dependent diabetes, diabetic retinopathy, diabetic neuropathy, and other diseases have used natural diabetes medications⁶⁸. The groups of plants with the most powerful hypoglycaemic impacts incorporate Liliaceae, Lamiaceae, Leguminoseae, Cucurbitaceae, Rosaceae, Moraceae, Asteraceae, Araliaceae and Euphorbiaceae⁶⁹. The most regularly examined species were Momordica charantia,Emblica officinalis, Trigonella foenum-graecum,Cinnamomum verum,Gymnema Sylvestre,Acacia Arabica,Abroma augusta, Acalypha wilkesiana,Acorus calamus,Aegle marmelos, Afzelia Africana,Alhagi camelorum,Allium sattivum, Aloe barbadensis miller, Alpinia officinarum, Amaranthus spinosus, Amaranthus viridis,Annona squamosa, Anogeissus acuminate,Areca catechu, Artemisia dracunculus (L.), Artemisia pallens⁷⁰. Different components may also be included, for example, increment of fringe use of glucose, increment of blend of hepatic glycogen or reduction of glycogenolysis, restraint of intestinal glucose retention, decrease of glycemic list of sugars, and decrease in the impact of glutathione⁷¹. In this audit, normal items are ordered into terpenoids, alkaloids, flavonoids, and phenolics, and some different classifications have appeared potential through the insulin-mimetic movement of the plant. Roseoside, epigallocatechin gallate, beta-pyrazol-1-ylalanine, cinchonain, leucocyandin 3-O-beta-d-galactosyl cellobioside, leucopelargonidin-3-O-alpha-L rhamnoside, glycyrrhetinic corrosive, dehydrotrametenolic corrosive, strictinin, isostrictinin, pedunculagin, epicatechin, and christinin-A confined from plant material have demonstrated huge insulinomimetic movement alongside critical anti-diabetic potential⁷². Moreover, a few flavonoids and polyphenols, just as sugar subordinates, are compelling because of other extra-pancreatic instruments⁷³.

This study delves into various anti-diabetic plants used in the management of diabetes mellitus, highlighting their phytoconstituents, which include coumarins, flavonoids, polyphenols, and terpenoids. Flavonoids, which include flavan-3-ols, flavanones, flavonols, anthocyanidins, flavones, isoflavones, and terpenoids, including diterpenoids, monoterpenoids, polyterpenoids, and triterpenoids, are prominent in these plants⁷⁴. Additionally, phenolic compounds, such as eugenol, eugenol acetic acid, and gallic acid, are prevalent. Research findings suggest that these plants possess hypoglycemic effects and can be utilized to manage various secondary complications of diabetes mellitus, often exhibiting insulin-mimicking properties⁷⁵.

In this study, 33 plants were incorporated, which demonstrated anti-diabetic activity through the release of insulin and some additional pancreatic instruments.

CONCLUSION:

The utilization of medicinal plants, as reported by respondents, has a diverse range of applications, including healing properties and socioeconomic improvements. This research is expected to contribute to the preservation of inherited knowledge related to herbal medicine and the general use of plants in village ecosystems.

In conclusion, the utilization of indigenous plants in traditional medicine for treating DM in India offers promising avenues. However, the review acknowledges the need for further exploration and research to unveil the therapeutic mechanisms, prognostic implications, and specific clinical guidelines for managing both Type 1 and Type 2 DM effectively.

This review provides valuable insights into medicinal plants that have demonstrated prolonged benefits in the treatment of diabetes. These plants have the potential to be beneficialfor the treatment of insulin-related conditions in the future, particularly within tribal communities.

Future Research Directions:

Current diabetes treatments primarily use synthetic drugs such as sulphonylureas and biguanides, which often have side effects. Researchers are turning to plant-derived anti-diabetic drugs for their effectiveness and fewer side effects. Historically, many plant-based medicines have been used for diabetes due to their safety, cost-effectiveness, and availability. Phytochemicals, like quercetin, berberine, and chlorogenic acid, have shown anti-diabetic properties through mechanisms such as enzyme inhibition and improved insulin sensitivity.

To compose a future free from autoimmune discord, comprehensive research on DM, incorporating traditional plant management, takes center stage. Prioritizing studies on incidence, trends, and prevalence ensures a symphonic understanding. Nuanced research on traditional medicinal plants, through clinical trials and interdisciplinary collaborations, paves the way for evidence-based integration. Community engagement, education programs, and policy advocacy create the final chords, harmonizing India's healthcare symphony against autoimmune diseases like DM.

CONFLICT OF INTEREST:

The authors have no conflicts of interest regarding this investigation.

ACKNOWLEDGMENTS:

We are also showing our gratitude towards Columbia College of Pharmacy, Raipur for providing all facilities for easy conducting of the research.

REFERENCES:

1. Khan Z, Gupta G Das, Mehan S. Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges. J Clin Med. 2023;12(13). doi:10.3390/jcm12134274

2. Gawda A, Majka G, Nowak B, Śróttek M, Walczewska M, Marcinkiewicz J. Air particulate matter SRM 1648a primes macrophages to hyperinflammatory response after LPS stimulation. Inflamm Res. 2018; 67(9): 765-776. doi:10.1007/s00011-018-1165-4

3. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996; 383(6603): 787-793. doi:10.1038/383787a0

4. McCor-mack JE, Callahan JE, Kappler J, et al. 67. F. Vignaux and P. Golstein. 88 J B Weinb a!, ibid. 1994;10(March):497.

5. Volkmar FR, State M, Klin A. Autism and autism spectrum disorders: Diagnostic issues for the coming decade. J Child Psychol Psychiatry Allied Discip. 2009; 50(1-2): 108-115. doi:10.1111/j.1469-7610.2008.02010.x

6. Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int. 2009; 75(12): 1264-1271. doi:10.1038/ki.2009.32

7. Uppal P, Mohammed SA, Rajashekar S, et al. Type 2 Diabetes Mellitus and Asthma: Pathomechanisms of Their Association and Clinical Implications. Cureus. 2023; 15(3): 4-11. doi:10.7759/cureus.36047

8. Kopf S, Kumar V, Kender Z, et al. Diabetic Pneumopathy–A New Diabetes-Associated Complication: Mechanisms, Consequences and Treatment Considerations. Front Endocrinol (Lausanne). 2021; 12(November):1-11. doi:10.3389/fendo.2021.765201

9. Tripathi BK, Srivastava AK. Diabetes mellitus: Complications and therapeutics. Med Sci Monit. 2006; 12(7): 130-147.

10. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018; 14(2): 88-98. doi:10.1038/nrendo.2017.151

11. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006; 49(8): 1711-1721. doi:10.1007/s00125-006-0316-2

12. Pola S, Kadali VN. Medicinal Plants of West Godavari. Drug Discov - Concepts to Mark. 2018. doi:10.5772/intechopen.73499

13. Upadhyay RP, Misra P, Chellaiyan VG, et al. Burden of diabetes mellitus and prediabetes in tribal population of India: A systematic review. Diabetes Res Clin Pract. 2013; 102(1): 1-7. doi:10.1016/j.diabres.2013.06.011

14. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: Translating evidence into action. Health Aff. 2001; 20(6): 64-78. doi:10.1377/hlthaff.20.6.64

15. Kapoor D, Bhardwaj AK, Kumar D, Raina SK. Prevalence of Diabetes Mellitus and Its Risk Factors among Permanently Settled Tribal Individuals in Tribal and Urban Areas in Northern State of Sub-Himalayan Region of India. Int J Chronic Dis. 2014; 2014: 1-9. doi:10.1155/2014/380597

16. Sachdev B. Community based study on incidence of type 2 diabetes and hypertension among nomad tribal population of Rajasthan, India. Int J Sci Nat. 2011; 2(2): 296-301.

17. Kala CP, Dhyani PP, Sajwan BS. Developing the medicinal plants sector in northern India: Challenges and opportunities. J Ethnobiol Ethnomed. 2006;2(August 2006). doi:10.1186/1746-4269-2-32

18. Bhattacharya P, Prasad R, Bhattacharyya R, Asokan A. plants in four Indian states. 2008;59(December):35-44.

19. Poincelot RP, Flagler J. People-Plant Relationships: Setting Research Priorities.; 2018. doi:10.1201/9780203743942

20. Engelhart MD, Moughamian H. Book Reviews : Book Reviews. Educ Psychol Meas. 1968; 28(3): 951-951. doi:10.1177/001316446802800332

21. Awad N, Gagnon M, Messier C. The Relationship between Impaired Glucose Tolerance, Type 2 Diabetes, and Cognitive Function. Vol 26.; 2004. doi:10.1080/13803390490514875

22. Ali Hussain HEM. Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn, and partially purified product from Abroma augusta, Linn. in streptozotocin induced diabetes. Indian J Clin Biochem. 2002;17(2):33-43. doi:10.1007/BF02867969

23. El AY, Abdel N, Azzaz KE, Mahmoud HI. diabetic rats. 2014;5(3):430-439. doi:10.5155/eurjchem.5.3.430

24. Najib A, Hartati S, Elya B. In vitro bioassay of n-buthanol isolate of Acorus calamus L. on inhibitory of activity a-glucosidase. Int J PharmTech Res. 2011;3(4):2085-2088.

25. Gholamhoseinian A, Shahouzebi B, Sharifi-far F. Inhibitory effect of some plant extracts on Pancreatic Lipase. Int J Pharmacol. 2010;6(1):18-24. doi:10.3923/ijp.2010.18.24

26. Rajasekaran S, Sivagnanam K, Ravi K, Subramanian S. Hypoglycemic Effect of Aloe vera Gel on Streptozotocin-Induced. J Med Food. 2004;7(July 2003):61-66.

27. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, Duke SO. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem. 2002;50(12):3453-3457. doi:10.1021/jf0116855

28. Senthil Amudhan M, Hazeena Begum V. Alpha-glucosidase inhibitory and hypoglycemic activities of Areca catechu extract. Pharmacogn Mag. 2008;4(15):223-227.

29. Pahlavani N, Roudi F, Zakerian M, et al. Possible molecular mechanisms of glucose-lowering activities of Momordica charantia (karela) in diabetes. J Cell Biochem. 2019;120(7):10921-10929. doi:10.1002/jcb.28483

30. Variya BC, Bakrania AK, Patel SS. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacol Res. 2016;111:180-200. doi:10.1016/j.phrs.2016.06.013

31. Abd El Aty HE, Zaazaa AM, Mohamed SH, El Dayem SA, Foda F. Promising Therapeutic Efficacy of Trigonella-foenum graecum and Bone Marrow-Derived Mesenchymal Stem Cells on Skeletal Muscle Atrophy in Experimental Rat Model. Biointerface Res Appl Chem. 2023;13(2):1-19. doi:10.33263/BRIAC132.133

32. Jangam A, Tirunavalli SK, Adimoolam BM, et al. Anti-inflammatory and antioxidant activities of Gymnema Sylvestre extract rescue acute respiratory distress syndrome in rats via modulating the NF-κB/MAPK pathway. Inflammopharmacology. 2023;31(2):823-844. doi:10.1007/s10787-022-01133-5

33. Rather GJ, Hamiduddin H, Ikram M, Naquibuddin M. Formulation and in vitro Evaluation of Tablet Dosage form of Unani Anti-diabetic Powder Containing Gymnema sylvestre R. Br, Syzygium cuminii Linn. and Zingiber officinale Rosc. Pharmacognosy Res. 2023; 15(3): 566-577. doi:10.5530/pres.15.3.060

34. Hazra K, Dutta S, Mandal AK, Ravte RK, Mitra A, Hazra J. Pharmacognostical and phytochemical blueprint of abroma augusta l. Stem bark. Indian J Nat Prod Resour. 2021; 12(2): 271-280. doi:10.56042/ijnpr.v12i2.24981

35. Batiha GES, Akhtar N, Alsayegh AA, et al. Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Genus Acacia. Molecules. 2022; 27(21): 1-22. doi:10.3390/molecules27217340

36. Anokwuru CP, Sinisi A, Samie A, Taglialatela-Scafati O. Antibacterial and antioxidant constituents of Acalypha wilkesiana. Nat Prod Res. 2015; 29(12): 1180-1183. doi:10.1080/14786419.2014.983105

37. Zhao Y, Li J, Cao G, et al. Ethnic, Botanic, Phytochemistry and Pharmacology of the Acorus L. Genus: A Review. Molecules. 2023;28(20). doi:10.3390/molecules28207117

38. Venthodika A, Chhikara N, Mann S, Garg MK, Sofi SA, Panghal A. Bioactive compounds of Aegle marmelos L., medicinal values and its food applications: A critical review. Phyther Res. 2021;35(4):1887-1907. doi:10.1002/ptr.6934

39. Vigbedor BY, Osei Akoto C, Kwakye R, Osei-Owusu J, Neglo D, Kwashie P. Antioxidant, antibacterial, antifungal activities and gas chromatographic fingerprint of fractions from the root bark of Afzelia africana. Int J Biochem Mol Biol. 2022; 13(6): 60-76.

40. Urabee MC, Abdulsattar JO, Nasif ZN, Al-Garawi ZS. Extraction methods of Alhagi Maurorum (camel thorn) and its therapeutic applications. J Phys Conf Ser. 2021; 1853(1). doi:10.1088/1742-6596/1853/1/012053

41. Alam A, Al Arif Jahan A, Bari MS, et al. Allium vegetables: Traditional uses, phytoconstituents, and beneficial effects in inflammation and cancer. Crit Rev Food Sci Nutr. 2023;63(23):6580-6614. doi:10.1080/10408398.2022.2036094

42. Kaur S, Bains K. Aloe Barbadensis Miller (Aloe Vera) Pharmacological activities and clinical evidence for disease prevention. Int J Vitam Nutr Res. 2024; 94(3-4): 308-321. doi:10.1024/0300-9831/a000797

43. Putra WE, Sustiprijatno, Hidayatullah A, Widiastuti D, Heikal MF, Salma WO. Virtual Screening of Natural Alpha-Glucosidase Inhibitor From Alpinia Galanga Bioactive Compounds As Anti-Diabetic Candidate. J Microbiol Biotechnol Food Sci. 2023;13(1):1-5. doi:10.55251/jmbfs.4353

44. Phoswa WN, Mokgalaboni K. Comprehensive Overview of the Effects of Amaranthus and Abelmoschus esculentus on Markers of Oxidative Stress in Diabetes Mellitus. Life. 2023; 13(9). doi:10.3390/life13091830

45. Pratap Singh R, Pattnaik AK. Anti-obesity potential of bioactive guided fractions of A nnona squamosa linn. leaves extract: a combination of in-vitro, in-vivo and in-silico studies along with profiling of lead compounds by HPTLC MS-MSn method. 3 Biotech. 2023;13(6):1-14. doi:10.1007/s13205-023-03603-1

46. Maqsood R, Khan F, Ullah S, et al. Evaluation of Antiproliferative, Antimicrobial, Antioxidant, Antidiabetic and Phytochemical Analysis of Anogeissus dhofarica A. J. Scott. Antibiotics. 2023;12(2). doi:10.3390/antibiotics12020354

47. Sable PD, Kadam KA, Gangurde HH, Chavan PS, Ingle PD. Medicinal and pharmacological action of various herbs on Diabetes mellitus: A review. IOSR J Pharm. 2023; 13(March):1-09.

48. Ibrahim KG, Mukonowenzou NC, Usman D, Adeshina KA, Erlwanger KH. The potential of Artemisia species for use as broad-spectrum agents in the management of metabolic syndrome: a review. Arch Physiol Biochem. 2023; 129(3): 752-770. doi:10.1080/13813455.2021.1871761

49. Sohail J, Zubair M, Hussain K, et al. Pharmacological activities of Artemisia absinthium and control of hepatic cancer by expression regulation of TGFβ1 and MYC genes. PLoS One. 2023; 18(4 APRIL): 1-27. doi:10.1371/journal.pone.0284244

50. Núbia Alves Mariano TPG, Germano Guarim N, Marcos Pereira M, Lucilia K, Vanessa Gisele PS. Ethnobotanical and ethnopharmacological survey of medicinal species utilized in the Coqueiros Community, Brazils. Bol Latinoam y del Caribe Plantas Med y Aromat. 2022; 21(6): 671-715. doi:10.37360/blacpma.22.21.6.42

51. Zhang W, Zhao Z, Chang L, Cao Y, Wang S, Kang C. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’ s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories , such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source . These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Atractylodis Rhizoma : A review of its traditional uses , phytochemistry, pharmacology, toxicology and quality control. 2020;(January).

52. Satyanarayana K, Sravanthi K, Shaker I, Ponnulakshmi R. Molecular approach to identify antidiabetic potential of Azadirachta indica. J Ayurveda Integr Med. 2015; 6(3): 165-174. doi:10.4103/0975-9476.157950

53. He X, Yang Y, Yuan X, Sun Y, Li Y. Anti-Nociceptive and Anti-Inflammatory Activities of the Ethyl Acetate Extract of Belamcanda chinensis (L.) Redouté in Raw 264.7 Cells in vitro and Mouse Model in vivo. J Pain Res. 2022; 15: 1221-1232. doi:10.2147/JPR.S353357

54. Alsaadi SARA, Abass KS. Benincasa hispida is an antioxidant of possible physiological importance: A comparative review. Plant Arch. 2020;20:2833-2838.

55. Belwal T, Bisht A, Devkota HP, et al. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Front Pharmacol. 2020; 11(February): 1-27. doi:10.3389/fphar.2020.00041

56. Bouchmaa N, Mrid R Ben, Kabach I, et al. Beta vulgaris subsp. maritima: A Valuable Food with High Added Health Benefits. Appl Sci. 2022; 12(4). doi:10.3390/app12041866

57. Anand U, Nandy S, Mundhra A, Das N, Pandey DK, Dey A. A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: Possible therapeutic approaches against multidrug resistance in pathogenic microorganisms. Drug Resist Updat. 2020; 51(March): 100695. doi:10.1016/j.drup.2020.100695

58. Batiha GES, Alkazmi LM, Wasef LG, Beshbishy AM, Nadwa EH, Rashwan EK. Syzygium aromaticum l. (myrtaceae): Traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules. 2020; 10(2): 1-17. doi:10.3390/biom10020202

59. Dey P, Singh J, Suluvoy JK, Dilip KJ, Nayak J. Utilization of Swertia chirayita Plant Extracts for Management of Diabetes and Associated Disorders: Present Status, Future Prospects and Limitations. Nat Products Bioprospect. 2020; 10(6): 431-443. doi:10.1007/s13659-020-00277-7

60. Khaliq T, Akhter S, Sultan P, Hassan QP. Critical review on Rumex dentatus L. a strong pharmacophore and the future medicine: Pharmacology, phytochemical analysis and traditional uses. Heliyon. 2023; 9(3): e14159. doi:10.1016/j.heliyon.2023.e14159

61. Yahaya TO, Liman UU, Obadiah CD, et al. Environmental Triggers’ Involvement in the Development of Type 1 Diabetes Mellitus. Explor Res Hypothesis Med. 2022;000(000):000-000. doi:10.14218/erhm.2022.00051

62. Zhang L, Wei K, Xu J, et al. Belamcanda chinensis (L.) DC-An ethnopharmacological, phytochemical and pharmacological review. J Ethnopharmacol. 2016; 186: 1-13. doi:10.1016/j.jep.2016.03.046

63. Krishnamoorthy Y, Rajaa S, Verma M, Kakkar R, Kalra S. Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys. Diabetes Ther. 2023; 14(1): 63-75. doi:10.1007/s13300-022-01329-6

64. Narayan KMV, Varghese JS, Beyh YS, et al. A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda. J Indian Inst Sci. 2023; 103(1): 33-54. doi:10.1007/s41745-022-00354-5

65. Nivedita Rawat, Sharddha Sharma. Role of Ayurvedic Medicinal Plants in Auto-immune disorders and their management. J Ayurveda Integr Med Sci. 2023; 8(3): 108-115. doi:10.21760/jaims.8.3.20

66. Balwan WK, Saba N, Zargar JI. Burden of Diabetes and Role of Medicinal Plants in Its Treatment. Saudi J Med Pharm Sci. 2022; 8(7): 355-361. doi:10.36348/sjmps.2022.v08i07.006

67. Khan W, Zahiruddin S, Ahmad S. Diabetes-Associated Complications and Some Indian Traditional Plants Used for Its Management. Vol 66. 1st ed. Elsevier B.V.; 2020. doi:10.1016/B978-0-12-817907-9.00005-2

68. Ogbonna Abigail I, Ogbonna Sonia Ugoy A, Ugwu Eugene I, et al. Biochemical Analysis and Antimicrobial Activity of Ethanolic and Aqueous Leaf Extracts of Acalypha wilkesiana var morea Müll.Arg. (Copperleaf). J Bot Res. 2021; 4(1). doi:10.36959/771/570

69. Hannan JMA, Nipa N, Toma FT, Talukder A, Ansari P. Acute Anti-Hyperglycaemic Activity of Five Traditional Medicinal Plants in High Fat Diet Induced Obese Rats. Front Biosci - Sch. 2023; 15(2). doi:10.31083/j.fbs1502005

70. Ali Esmail Al-Snafi. Medicinal plants with hypoglycemic effect: A review. GSC Biol Pharm Sci. 2023; 24(1): 147-173. doi:10.30574/gscbps.2023.24.1.0274

71. Gargantiel, Faller EM. A Perspective Review On Diabetes Mellitus And The Potential Antidiabetic Activity Of Medicinal Plants. Int J Sci Technol Res. 2021; 10(06): 188-202.

72. Ahmad W, Amir M, Ahmad A, et al. Aegle marmelos leaf extract phytochemical analysis, cytotoxicity, in vitro antioxidant and antidiabetic activities. Plants. 2021; 10(12): 1-13. doi:10.3390/plants10122573

73. Vellapandian C, Rini R, Ramachandram DS. Renoprotective activity of anethole- rich fraction from aromatic herbs on junk food induced diabetic nephropathy in rats. J Diabetes Metab Disord. 2022; 21(2): 1557-1567. doi:10.1007/s40200-022-01101-4

74. Lochana L. Malode, Jagdish V. Manwar, Wrushali A. Panchale, Shivam A. Bartere, Ravindra L. Bakal. Potential of medicinal plants in management of diabetes: An updates. GSC Adv Res Rev. 2021; 8(1): 149-169. doi:10.30574/gscarr.2021.8.1.0151

75. 77.Biochemistry Research International - 2022 - Vigbedor - Bioassay‐Guided Fractionation ESI‐MS Scan Phytochemical Screening.pdf.

Received on 02.02.2024 Revised on 13.06.2024

Accepted on 11.09.2024 Published on 28.01.2025

Available online from February 27, 2025

Research J. Pharmacy and Technology. 2025;18(2):927-934.

DOI: 10.52711/0974-360X.2025.00136

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.